
William A. Craigo
Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 936 |
| Issued Applications | 383 |
| Pending Applications | 126 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17980400
[patent_doc_number] => 20220346436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => ORALLY DISSOLVING FILMS
[patent_app_type] => utility
[patent_app_number] => 17/726121
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726121 | ORALLY DISSOLVING FILMS | Apr 20, 2022 | Pending |
Array
(
[id] => 18550761
[patent_doc_number] => 20230248761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Method for supporting normal blood calcium concentrations in mammals
[patent_app_type] => utility
[patent_app_number] => 17/722789
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722789 | Method for supporting normal blood calcium concentrations in mammals | Apr 17, 2022 | Pending |
Array
(
[id] => 20320028
[patent_doc_number] => 20250332116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-30
[patent_title] => CARBON-BASED ANTI VIRAL NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/555389
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555389
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555389 | CARBON-BASED ANTI VIRAL NANOPARTICLES | Apr 11, 2022 | Abandoned |
Array
(
[id] => 18690980
[patent_doc_number] => 20230321158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/716892
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716892
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716892 | COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF | Apr 7, 2022 | Abandoned |
Array
(
[id] => 19232298
[patent_doc_number] => 20240189490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => ANTIMICROBIAL ELUTING AIRWAY DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/553893
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553893
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553893 | ANTIMICROBIAL ELUTING AIRWAY DEVICES | Apr 7, 2022 | Pending |
Array
(
[id] => 18690995
[patent_doc_number] => 20230321175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => ANTI-DIABETIC STEROIDAL LACTONES OF WITHANIA COAGULANS FOR TREATMENT OF TYPE 2 DIABETES
[patent_app_type] => utility
[patent_app_number] => 17/716189
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716189 | ANTI-DIABETIC STEROIDAL LACTONES OF WITHANIA COAGULANS FOR TREATMENT OF TYPE 2 DIABETES | Apr 7, 2022 | Abandoned |
Array
(
[id] => 17748044
[patent_doc_number] => 20220226247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => STABLE HOT-MELT EXTRUDATE CONTAINING VALSARTAN AND SACUBITRIL
[patent_app_type] => utility
[patent_app_number] => 17/715322
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715322 | STABLE HOT-MELT EXTRUDATE CONTAINING VALSARTAN AND SACUBITRIL | Apr 6, 2022 | Abandoned |
Array
(
[id] => 17748059
[patent_doc_number] => 20220226262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => METHODS OF TREATING DOOSE SYNDROME USING FENFLURAMINE
[patent_app_type] => utility
[patent_app_number] => 17/713856
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713856
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713856 | METHODS OF TREATING DOOSE SYNDROME USING FENFLURAMINE | Apr 4, 2022 | Abandoned |
Array
(
[id] => 17911246
[patent_doc_number] => 20220313641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => SPREADABLE NUTRITIONAL SUPPLEMENT AND SPREADABLE MEDICINE
[patent_app_type] => utility
[patent_app_number] => 17/713843
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713843 | SPREADABLE NUTRITIONAL SUPPLEMENT AND SPREADABLE MEDICINE | Apr 4, 2022 | Abandoned |
Array
(
[id] => 18281905
[patent_doc_number] => 20230097377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Biodegradable Implant Including Naltrexone
[patent_app_type] => utility
[patent_app_number] => 17/711910
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711910 | Biodegradable implant including naltrexone | Mar 31, 2022 | Issued |
Array
(
[id] => 17836295
[patent_doc_number] => 20220273600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/699892
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699892
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699892 | LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF | Mar 20, 2022 | Abandoned |
Array
(
[id] => 19140519
[patent_doc_number] => 20240139310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => MICROPARTICLE COMPOSITIONS AND METHODS USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/279459
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279459
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279459 | MICROPARTICLE COMPOSITIONS AND METHODS USE THEREOF | Mar 8, 2022 | Abandoned |
Array
(
[id] => 20348429
[patent_doc_number] => 20250345281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => METHODS FOR THE EXTRACTION OF DISPERSIBLE MICROCAPSULES (IMMUNOCONTRACEPTION)
[patent_app_type] => utility
[patent_app_number] => 18/278905
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278905
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278905 | METHODS FOR THE EXTRACTION OF DISPERSIBLE MICROCAPSULES (IMMUNOCONTRACEPTION) | Feb 24, 2022 | Abandoned |
Array
(
[id] => 19140332
[patent_doc_number] => 20240139108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE
[patent_app_type] => utility
[patent_app_number] => 18/547260
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547260
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547260 | ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE | Feb 24, 2022 | Abandoned |
Array
(
[id] => 19691229
[patent_doc_number] => 20250009774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM
[patent_app_type] => utility
[patent_app_number] => 18/547934
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547934
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547934 | COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM | Feb 22, 2022 | Pending |
Array
(
[id] => 17640694
[patent_doc_number] => 20220168432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/675842
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675842 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES | Feb 17, 2022 | Abandoned |
Array
(
[id] => 17836363
[patent_doc_number] => 20220273668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => IRAK4 DEGRADERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/651201
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651201 | IRAK4 degraders and uses thereof | Feb 14, 2022 | Issued |
Array
(
[id] => 17895345
[patent_doc_number] => 20220305007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => INJECTABLE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/650822
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650822 | INJECTABLE FORMULATION | Feb 10, 2022 | Abandoned |
Array
(
[id] => 18351014
[patent_doc_number] => 20230139125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => DIETARY SUPPLEMENT FOR IMPROVING BRAIN PERFORMANCE
[patent_app_type] => utility
[patent_app_number] => 17/912371
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912371 | DIETARY SUPPLEMENT FOR IMPROVING BRAIN PERFORMANCE | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17609816
[patent_doc_number] => 20220152095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => ELECTROLYTE COMPOSITION AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/587463
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/587463 | ELECTROLYTE COMPOSITION AND METHODS OF USE | Jan 27, 2022 | Pending |